Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study

BackgroundCardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality among long-term heart transplant recipients. There is an unmet need for a non-invasive biomarker of CAV that could obviate the need to perform surveillance coronary angiograms in these patients. Our aim w...

Full description

Bibliographic Details
Main Authors:	Marta Jiménez-Blanco Bravo, Laura Pérez-Gómez, Francisco J. Hernández-Pérez, Carlos Arellano-Serrano, Mario Torres-Sanabria, Manuel Gómez-Bueno, Juan F. Oteo-Domínguez, Susana Mingo-Santos, Javier Segovia-Cubero
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	donor-derived cell free DNA cardiac allograft vasculopathy coronariography biomarker NTproBNP cardiac troponin
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.856600/full

Similar Items

IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease
by: Anna Lisowska, et al.
Published: (2022-02-01)

Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study
by: L.M.G. Meems, et al.
Published: (2022-04-01)

N-Terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) Serum Concentrations in Apparently Healthy Bosnian Women
by: Almira Hadžović-Džuvo, et al.
Published: (2007-11-01)

Natriuretic peptide biomarkers in the imminent development of preeclampsia
by: Stefanie Marek-Iannucci, et al.
Published: (2023-07-01)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
by: Mihai Marinescu, et al.
Published: (2023-04-01)

Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention
by: Mathijs C. Bodde, et al.
Published: (2019-01-01)

Individualized Perioperative Hemodynamic Management Using Hypotension Prediction Index Software and the Dynamics of Troponin and NTproBNP Concentration Changes in Patients Undergoing Oncological Abdominal Surgery
by: Jolanta Cylwik, et al.
Published: (2024-02-01)

ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CARDIAC ALLOGRAFT VASCULOPATHY DEVELOPMENT
by: V. V. Chestukhin, et al.
Published: (2013-03-01)

Pathogenetic Significance of Antimicrobial Peptides in the Implementation of Antibacterial Protection in Children with Cystic Fibrosis
by: G.O. Lezhenko, et al.
Published: (2013-04-01)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
by: Kobashigawa Jon
Published: (2000-12-01)

Factors associated with cardiac allograft vasculopathy after heart transplantation
by: Wioletta Szczurek-Wasilewicz, et al.
Published: (2022-10-01)

Reduced left atrial contractile strain with speckle tracking analysis predicts abnormal plasma NTproBNP in an asymptomatic community population
by: Lin Liu, et al.
Published: (2022-11-01)

Can chronic heart failure induce kidney function damage?
by: Kimak Elzbieta, et al.
Published: (2016-04-01)

The Interplay between Myocardial Fibrosis, Strain Imaging and Collagen Biomarkers in Adults with Repaired Tetralogy of Fallot
by: Konstantina Karali, et al.
Published: (2021-11-01)

CLINIC EFFICIENCY OF MYOCARDIAL REVASCULARIZATION FOR CARDIAC ALLOGRAFT VASCULOPATHY
by: B. L. Mironkov, et al.
Published: (2014-12-01)

Relation of the renin–angiotensin–aldosterone system with potential cardiac injury and remodelling: the SABPA study
by: Lebo F. Gafane-Matemane, et al.
Published: (2020-01-01)

Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
by: Moaz A. Kamel, et al.
Published: (2024-03-01)

Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
by: Bibhuti B. Das, et al.
Published: (2022-07-01)

Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
by: Eilon Ram, et al.
Published: (2019-09-01)

Analysis of the risk factors for allograft vasculopathy in asymptomatic patients after cardiac transplantation
by: Fernando Bacal, et al.
Published: (2000-11-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Outcomes of percutaneous coronary intervention of chronic total occlusions in heart transplant recipients
by: Jorge Solano-López Morel, et al.
Published: (2019-08-01)

PREGNANCY-ASSOCIATED PLASMA PROTEIN A (PAPP-A) IN CARDIAC ALLOGRAFT VASCULOPATHY
by: О. P. Shevchenko, et al.
Published: (2011-06-01)

Functional Assessment of Long-Term Microvascular Cardiac Allograft Vasculopathy
by: Noemi Bora, et al.
Published: (2023-12-01)

NT-proBNP y variables pronósticas en el infarto agudo del miocardio.
by: Orlando Álvarez Toledo, et al.
Published: (2012-03-01)

Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling
by: Huijuan Zou, et al.
Published: (2021-03-01)

Continuous femoral nerve block enhances outcome of spinal anaesthesia in preventing perioperative cardiac complications in patients with cardiac risk
by: A G Yacout, et al.
Published: (2023-12-01)

Gender aspects of incidence of antibody-mediated rejection and allograft vasculopathy events after heart transplantation
by: N. N. Koloskova, et al.
Published: (2019-05-01)

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts
by: Camila Iansen Irion, et al.
Published: (2020-08-01)

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
by: Pooja Prasad, et al.
Published: (2023-10-01)

Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
by: Zhenggang Zhang, et al.
Published: (2021-03-01)

Ethnic disparities in cardiac transplantation: opportunities to improve long-term outcomes in all cardiac transplant recipients
by: Jeremy Kobulnik, et al.
Published: (2019-06-01)

Biosensors for the Rapid Detection of Cardiovascular Biomarkers of Vital Interest: Needs, Analysis and Perspectives
by: Laure Abensur Vuillaume, et al.
Published: (2022-11-01)

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation
by: Moritz Benjamin Immohr, et al.
Published: (2023-11-01)

Therapeutic potential role of vitamin C in prevention and control of heart transplant rejection and cardiac allograft vasculopathy. A need for consideration
by: Idd J. Kenedy, et al.
Published: (2023-11-01)

Cardiac effects of positive pressure ventilation in ARDS assessed by NT-proBNP, Troponin T and Troponin I
by: Yasser Sadek Nassar, et al.
Published: (2013-01-01)

De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival
by: Guillaume Baudry, et al.
Published: (2022-06-01)

Biomarkers Associated with Cardiovascular Disease in COVID-19
by: Christoph C. Kaufmann, et al.
Published: (2022-03-01)

An agent-based model of cardiac allograft vasculopathy: toward a better understanding of chronic rejection dynamics
by: Elisa Serafini, et al.
Published: (2023-09-01)

Intravascular visualization methods in estimating vasculopathy of a transplanted heart
by: S. A. Sakhovsky, et al.
Published: (2019-05-01)